This $250,000.00 federal contract award to Critical Innovations LLC is for the Defense Health Agency's (DHA) Small Business Innovation Research (SBIR) Phase I project titled "SUCCOR COMBAT FOAM FOR OPEN TRAUMATIC BRAIN INJURY MEDICAL R AND D". The contract is designated as a total small business set-aside and has a firm fixed price pricing type. Critical Innovations, a small business limited liability company, will be responsible for developing an innovative combat foam solution to address open traumatic brain injuries. This contract is part of the DHA's medical research and development efforts and is expected to be completed by May 6, 2025. Critical Innovations has previously received various SBIR Phase I, II, and III awards from defense agencies for the development of advanced medical technologies, including wound treatment, hemorrhage control, and automated diagnosis and treatment systems.
Generated 1/6/25, 12:27 PM